{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:02:47Z","timestamp":1783515767289,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ymgme.2024.108515","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:35:28Z","timestamp":1718307328000},"page":"108515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3"],"prefix":"10.1016","volume":"142","author":[{"given":"Astrid","family":"H\u00f8j","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Cathrine","family":"\u00d8rngreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Mostue","family":"Naume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Meldgaard","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108515_bb0005","series-title":"Lysosomal Storage Disease","author":"Rajkumar","year":"2022"},{"issue":"24","key":"10.1016\/j.ymgme.2024.108515_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.21037\/atm.2018.11.39","article-title":"Lysosomal storage disease overview","volume":"6","author":"Sun","year":"2018","journal-title":"Ann Transl Med."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson\u2019s disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"77","key":"10.1016\/j.ymgme.2024.108515_bb0025","first-page":"273","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"14","author":"Sidransky","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymgme.2024.108515_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ymgmr.2017.10.011","article-title":"Characteristics of 26 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher outcome survey","volume":"14","author":"Schwartz","year":"2018","journal-title":"Mol Genet Metab Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108515_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13023-022-02378-7","article-title":"Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease","volume":"17","author":"Donald","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108515_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0950-3536(97)80035-2","article-title":"5 Neuronopathic forms of Gaucher\u2019s disease","volume":"10","author":"Erikson","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"21","key":"10.1016\/j.ymgme.2024.108515_bb0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2014 macrophage-targeted Glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108515_bb0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher\u2019s disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2024.108515_bb0060","series-title":"Cochrane Database Syst Rev","article-title":"Hematopoietic stem cell transplantation for Gaucher disease","volume":"2021(4)","author":"Somaraju","year":"2017"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0065","first-page":"193","article-title":"Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children","volume":"1","author":"Shaw","year":"1986","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2024.108515_bb0070","series-title":"Supply shortages of Cerezyme and Fabrazyme - priority access for patients most in need treatment recommended","author":"EMA","year":"2024"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108515_bb0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","article-title":"The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: a review","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108515_bb0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","article-title":"Management of neuronopathic Gaucher disease: revised recommendations","volume":"32","author":"Vellodi","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108515_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-9-51","article-title":"Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease","volume":"9","author":"van Dussen","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108515_bb0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/humu.20524","article-title":"Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring","volume":"28","author":"Grace","year":"2007","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108515_bb0095","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108515_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1005367328003","article-title":"Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase","volume":"20","author":"Young","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108515_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/biom13030436","article-title":"A 20-year longitudinal study of plasma Chitotriosidase activity in treated Gaucher disease type 1 and 3 patients\u2014a qualitative and quantitative approach","volume":"13","author":"Szyma\u0144ska-Ro\u017cek","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108515_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-979754","article-title":"Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease","volume":"26","author":"Erikson","year":"1995","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev."},{"issue":"8938","key":"10.1016\/j.ymgme.2024.108515_bb0120","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(94)90462-6","article-title":"Enzyme replacement treatment in type 1 and type 3 Gaucher\u2019s disease","volume":"344","author":"Bembi","year":"1994","journal-title":"Lancet Lond Engl."},{"key":"10.1016\/j.ymgme.2024.108515_bb0130","series-title":"Ten Years\u2019 Experience of Bone Marrow Transplantation for Gaucher Disease","first-page":"864","volume":"59(6)","author":"Ringden","year":"1995"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108515_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30149","article-title":"Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3","volume":"70","author":"Anurathapan","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108515_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","article-title":"Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease","volume":"153","author":"Goker-Alpan","year":"2008","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08880018.2012.762076","article-title":"Gauchers disease\u2014a reappraisal of hematopoietic stem cell transplantation","volume":"30","author":"Ito","year":"2013","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108515_bb0155","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing Allo-antibodies observed in Hurler\u2019s syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108515_bb0160","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of Miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/17446651.2018.1445524","article-title":"Recent advances in the diagnosis and management of Gaucher disease","volume":"13","author":"Gary","year":"2018","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2024.108515_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpn.2021.03.013","article-title":"Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: a long-term outcome of two siblings","volume":"32","author":"Ramad\u017ea","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108515_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.576221","article-title":"Metachromatic Leukodystrophy: diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ymgme.2024.108515_bb0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fped.2019.00433","article-title":"Hematopoietic stem cell transplantation in inborn errors of metabolism","volume":"7","author":"Tan","year":"2019","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108515_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM198407123110203","article-title":"Bone-marrow transplantation in severe Gaucher\u2019s disease","volume":"311","author":"Rappeport","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108515_bb0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-198807000-00011","article-title":"Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease","volume":"46","author":"Ringd\u00e9n","year":"1988","journal-title":"Transplantation"},{"issue":"4\u20135","key":"10.1016\/j.ymgme.2024.108515_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000112184","article-title":"Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation","volume":"13","author":"Svennerholm","year":"1991","journal-title":"Dev. Neurosci."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108515_bb0210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1203\/00006450-199205000-00019","article-title":"Allogenic bone marrow transplantation in severe Gaucher disease","volume":"31","author":"Tsai","year":"1992","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108515_bb0215","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.tp.0000181457.43146.36","article-title":"Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:29:56Z","timestamp":1732220996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1096719224003998"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108515","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108515"}}